Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-03-27Clinical Trial Update: Epcoritamab-CAR T Cells for Large B-cell Lymphomas [Phase 2]
Phase 2 clinical trial evaluating epcoritamab-CAR T cells for large B-cell lymphomas, currently recruiting.
-
CLINICAL_TRIALS research · 2025-03-24Clinical Trial Update: CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER) [Phase 1]
A Phase 1 trial evaluating a CRISPR-edited allogeneic anti-CD19 CAR-T cell therapy (ANTLER) for relapsed/refractory B-cell non-Hodgkin lymph…
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: Study of the Association Between Fatigue Experienced by Patients and the Specific Side Effects of CART Cells, During the First Month After Administration for Non-Hodgkin's Lymphoma
A clinical trial update evaluating the association between fatigue and specific adverse events within the first month after CAR-T cell thera…
-
CLINICAL_TRIALS research · 2025-03-17Clinical Trial Update: JY231(JY231) Injection for the Treatment of Relapsed or Refractory B-Cell Lymphoma [NA]
Clinical trial update for JY231 injection for relapsed or refractory B-cell non-Hodgkin lymphoma; the study status is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-02-27Clinical Trial Update: Safety and Efficacy of EX103 in Subjects with Relapsed/Refractory CD20-Positive Non-Hodgkin Lymphoma [Phase 1, Phase 2]
This clinical trial update notes that EX103 is being studied in a Phase 1/2 trial for relapsed or refractory CD20-positive non-Hodgkin lymph…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-02-25Clinical Trial Update: PTCy and ATG for MSD and MUD Transplants [Phase 1, Phase 2]
Ongoing Phase 1/2 clinical trial evaluating post-transplant cyclophosphamide and anti-thymocyte globulin for matched sibling and matched unr…
-
CLINICAL_TRIALS research · 2025-02-25Clinical Trial Update: Evaluate the Safety, Tolerability, and Efficacy of ICP-490 in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating ICP-490 for relapsed or refractory non-Hodgkin lymphoma; the study status is NOT_YET_RECRUITING.
-
CLINICAL_TRIALS research · 2025-02-19Clinical Trial Update: Chidamide Combined With Linperlisibon for the Treatment of Refractory/Relapsed Follicular Lymphoma [Phase 2]
Phase 2 clinical trial evaluating chidamide in combination with linperlisib for refractory/relapsed follicular lymphoma is currently recruit…
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: Long-term Cognitive, Neuropsychiatric and Functional Outcomes in Adults Who Have Received Chimeric Antigen-Receptor T-Cell (CAR-T) Therapy for Aggressive Lymphoma at Stanford [NA]
Stanford’s clinical trial seeks to evaluate long-term cognitive, neuropsychiatric, and functional outcomes in adults treated with CAR-T ther…
-
CLINICAL_TRIALS research · 2025-02-07Clinical Trial Update: DS-3201b in Participants With Lymphomas [Phase 1]
Phase 1 clinical trial update for DS-3201b in participants with lymphoma, including non-Hodgkin lymphoma. The study is active but not recrui…
-
CLINICAL_TRIALS research · 2025-02-07Clinical Trial Update: Phase II Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 2]
A Phase II trial of CNCT19 cell therapy for relapsed or refractory Non-Hodgkin's lymphoma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-01-20Clinical Trial Update: A Novel CAR-T Combined Expression of IL-15 in the Treatment of Malignant Hematological Tumors [NA]
A Clinical Trial Update describes a novel CAR-T therapy expressing IL-15 for malignant hematological tumors, with recruitment ongoing and no…
-
CLINICAL_TRIALS research · 2025-01-06Clinical Trial Update: CART19 Cells Effects in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma [Phase 1]
A Phase 1 clinical trial evaluating CART19 cell therapy in patients with relapsed or refractory B-cell acute lymphoblastic leukemia and rela…
-
CLINICAL_TRIALS research · 2025-01-01Clinical Trial Update: Preventing of GVHD with Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Ruxolitinib At Children and Young Adults with Hemoblastosis [Phase 2, Phase 3]
A multi-agent trial in pediatric and young adult patients explores preventing graft-versus-host disease after transplantation using post-tra…
-
CLINICAL_TRIALS research · 2024-12-20Clinical Trial Update: Study of SIRPant-M in Participants With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 1]
A Phase 1 trial evaluating SIRPant-M in participants with relapsed or refractory Non-Hodgkin lymphoma is currently recruiting.
-
CLINICAL_TRIALS research · 2024-12-17Clinical Trial Update: A Phase 1 Study of FD-001 in Recurrent /Refractory (R/R)AML/NHL/MM/MDS [Phase 1]
A Phase 1 study of FD-001 in recurrent/refractory acute myeloid leukemia, non-Hodgkin lymphoma, multiple myeloma, and myelodysplastic syndro…
-
CLINICAL_TRIALS research · 2024-12-09Clinical Trial Update: CD19-directed CAR-T Cell Therapy for R/R Acute Leukemia and Lymphoma [Phase 1, Phase 2]
Ongoing Phase 1/2 clinical trial from the University of Sao Paulo evaluating a CD19-directed CAR-T cell therapy for relapsed/refractory acut…
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: Development of Prognostic Models for Response and Toxicity to CAR-T Cell Therapy in Patients with Relapsed/refractory Non Hodgkin's Lymphoma.
This clinical trial update describes the development of prognostic models to predict response and toxicity to CAR-T cell therapy in patients…
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: An Extension Study to Evaluate the Safety and Efficacy of an Anti-CD19 CAR-T Product in Patients with B-cell Lymphoproliferative Disorders
An extension study to evaluate the safety and efficacy of an anti-CD19 CAR-T product in patients with B-cell lymphoproliferative disorders, …
-
CLINICAL_TRIALS research · 2024-11-29Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With Polatuzumab Vedotin in B-Cell Non-Hodgkin Lymphoma [Phase 1, Phase 2]
Phase 1/2 clinical trial update evaluating the safety and efficacy of Mosunetuzumab in combination with Polatuzumab Vedotin in B-cell non-Ho…
-
CLINICAL_TRIALS research · 2024-11-20Clinical Trial Update: Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
Clinical trial update for a lentiviral gene therapy (Zamtocabtagene Autoleucel) in non-Hodgkin lymphoma, noting ongoing recruitment.
-
CLINICAL_TRIALS research · 2024-11-20Clinical Trial Update: A Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy Study of MBS303 in B-Cell NHL [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of MBS303 in…
-
CLINICAL_TRIALS research · 2024-10-21Clinical Trial Update: Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Non-Hodgkin Lymphoma [Phase 1]
Phase 1 trial evaluating BAFF CAR-T cells (LMY-920) for non-Hodgkin lymphoma is currently recruiting.
-
CLINICAL_TRIALS research · 2024-10-08Clinical Trial Update: A Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of CC-90010 in Subjects With Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin's Lymphomas [Phase 1]
A Phase 1 trial of CC-90010 in patients with advanced solid tumors and relapsed/refractory Non-Hodgkin's lymphomas has been terminated.
-
CLINICAL_TRIALS research · 2024-08-27Clinical Trial Update: A Real-World Study on Extranodal Lymphoma
A real-world study on extranodal lymphoma is registered at Ruijin Hospital and is not yet recruiting.